東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

The Role of Integrin alphaV in Oral ...

Barrett, Jeremy.

FindBook

Google Book

Amazon

博客來

The Role of Integrin alphaV in Oral Cancer.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	The Role of Integrin alphaV in Oral Cancer./
作者:	Barrett, Jeremy.
面頁冊數:	51 p.
附註:	Source: Masters Abstracts International, Volume: 54-04.
Contained By:	Masters Abstracts International54-04(E).
標題:	Oncology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=1587731
ISBN:	9781321719567

The Role of Integrin alphaV in Oral Cancer.
Barrett, Jeremy.

The Role of Integrin alphaV in Oral Cancer. - 51 p.

Source: Masters Abstracts International, Volume: 54-04.

Thesis (M.S.)--University of California, Los Angeles, 2015.

This item is not available from ProQuest Dissertations & Theses.

Background: Oral cancer constitutes 2-3% of carcinomas worldwide and results in more than 128,000 deaths each year. The most common form of oral cancer, squamous cell carcinoma (OSCC), is derived from the oral epithelium. Invasive OSCC is extremely destructive with high metastatic potential due to the high vasculature within the oral cavity. SOX-11 is a transcription factor that has been shown to be up-regulated in cancer and recent studies in our lab have suggested an increase in SOX-11 expression in higher invasive oral cancer cells. By using proteomic analysis, we have also demonstrated that knockdown of SOX-11 inhibited the expression of integrin alphaV (ITGAV) in oral cancer cells. However, the role and expression of ITGAV in oral cancer are not known.

ISBN: 9781321719567Subjects--Topical Terms:

751006
Oncology.

The Role of Integrin alphaV in Oral Cancer.
LDR:04061nmm a2200349 4500 001 2079193
005 20161210083249.5
008 170521s2015 ||||||||||||||||| ||eng d
020 $a 9781321719567
035 $a (MiAaPQ)AAI1587731
035 $a AAI1587731
040 $a MiAaPQ $c MiAaPQ
100 1 $a Barrett, Jeremy. $3 3194856
245 1 4 $a The Role of Integrin alphaV in Oral Cancer.
300 $a 51 p.
500 $a Source: Masters Abstracts International, Volume: 54-04.
500 $a Adviser: Shen Hu.
502 $a Thesis (M.S.)--University of California, Los Angeles, 2015.
506 $a This item is not available from ProQuest Dissertations & Theses.
520 $a Background: Oral cancer constitutes 2-3% of carcinomas worldwide and results in more than 128,000 deaths each year. The most common form of oral cancer, squamous cell carcinoma (OSCC), is derived from the oral epithelium. Invasive OSCC is extremely destructive with high metastatic potential due to the high vasculature within the oral cavity. SOX-11 is a transcription factor that has been shown to be up-regulated in cancer and recent studies in our lab have suggested an increase in SOX-11 expression in higher invasive oral cancer cells. By using proteomic analysis, we have also demonstrated that knockdown of SOX-11 inhibited the expression of integrin alphaV (ITGAV) in oral cancer cells. However, the role and expression of ITGAV in oral cancer are not known.
520 $a Objectives: The objective of our research is to investigate if SOX-11 regulates the expression of ITGAV in oral cancer cells and to examine the role of ITGAV in oral cancer. We will also demonstrate the differential expression of ITGAV among normal human oral keratinocytes (NHOK), and high and low invasive cancer cells.
520 $a Methods: Both SOX-11 and ITGAV expression in high (UM1 and UM5) and low (UM2 and UM6) invasive cells were measured using western blotting and qPCR. Chromatin immunoprecipitation (ChIP) assay and siRNA knockdown were used to examine if SOX-11 regulates ITGAV expression in oral cancer cells. Invasion, migration, and proliferation assays were performed to evaluate if ITGAV plays an important role in oral cancer cell proliferation and invasion.
520 $a Results: In silico analysis through the Genematix software suite and MatInspector identified one potential binding site of SOX-11 to the promoter region of ITGAV at 90% confidence. However, twelve additional SoxC group binding sites were located and cross regulation within the SoxC group has been noted in other genes. ChIP assay showed SOX-11 binds to the promoter region of ITGAV gene. After SOX-11 knockdown with siRNA (90% efficiency), ITGAV showed a 40% decrease matching to our previous finding by LC-MS/MS. Next, both western blotting and qPCR showed a significant over-expression of ITGAV (p < 0.01) in highly invasive cancer cells (UM1 and UM5) when compared to low-invasive cancer cells (UM2 and UM6). ITGAV was knocked down in invasive UM1 (95% knockdown) and UM5 (63% knockdown) with siRNA and phenotypic studies were preformed. Wound healing assay showed a 33.1% (UM1) and 40.8% (UM5) decrease in migration capability (p < 0.001), invasion assay showed a 68% (UM1) and 65% (UM5) decrease in invasion potential (p < 0.05), and proliferation assay showed a decreasing proliferation trend in the knockdown group with significant decrease at day 2 and 3 (UM1) and day 2 and 4 (UM5) (p < 0.05).
520 $a Conclusions: SOX-11 is a transcription factor that binds to the promoter region of ITGAV gene and may regulate the expression of ITGAV in oral cancer cells. ITGAV is significantly over-expressed in highly invasive cancer cells compared to low invasive cancer cells and may play an important role in oral cancer cell migration and invasion.
590 $a School code: 0031.
650 4 $a Oncology. $3 751006
650 4 $a Biology. $3 522710
650 4 $a Dentistry. $3 828971
690 $a 0992
690 $a 0306
690 $a 0567
710 2 $a University of California, Los Angeles. $b Oral Biology. $3 3194857
773 0 $t Masters Abstracts International $g 54-04(E).
790 $a 0031
791 $a M.S.
792 $a 2015
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=1587731